Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virus-Specific T Cells: Broadening Applicability.

A John Barrett1, Susan Prockop2, Catherine M Bollard3

  • 1Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|October 17, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Nature medicine·2026
Same author

A reassessment of anti-CAR T-cell expansion strategies.

Blood·2026
Same author

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same author

Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.

Transplantation and cellular therapy·2026
Same author

A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Focused ultrasound-enhanced cell therapy for brain tumors: Summary of roundtable discussions.

Neuro-oncology advances·2026
Same journal

ASTCT Notes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

ASTCT Notes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

End of headings.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

ASTCT Notes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

Improving Hematopoietic Stem Cell Transplant in the Elderly: Can We Finally Start to Impact Nonrelapse Mortality?

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2020
Same journal

Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2020
See all related articles

Adoptive transfer of virus-specific T lymphocytes (VSTs) offers a promising immunotherapy for viral infections post-hematopoietic stem cell transplantation (HSCT). This approach enhances antiviral immunity, overcoming limitations of conventional treatments.

Area of Science:

  • Immunology
  • Hematology
  • Virology

Background:

  • Virus infections are a major cause of death after hematopoietic stem cell transplantation (HSCT).
  • Current antiviral drugs are often expensive, toxic, and ineffective due to resistance.
  • Limited treatment options exist for certain viral infections like adenovirus and BK virus, especially after alternative donor transplants.

Purpose of the Study:

  • To review the advancements in virus-specific T lymphocyte (VST) therapy for viral infections after HSCT.
  • To explore strategies for expanding VST applicability beyond patient-specific products and HSCT contexts.

Main Methods:

  • Review of existing literature on VSTs in HSCT.
  • Analysis of VST efficacy and limitations.
  • Discussion of future directions for VST development and application.
Keywords:
Adoptive T cell therapyBK virusCytomegalovirusHIV

Related Experiment Videos

Main Results:

  • VSTs can rapidly restore antiviral immunity post-HSCT without causing graft-versus-host disease.
  • VSTs have improved outcomes for patients with life-threatening viral infections.
  • The field is exploring broader applications of VSTs for various viral diseases.

Conclusions:

  • Adoptive transfer of VSTs is a viable immunotherapeutic strategy for managing viral infections after HSCT.
  • Further research is needed to broaden VST applicability and address challenges in current treatments.
  • VSTs hold potential for treating a wider range of viral diseases.